Nuveen Asset Management, LLC Syndax Pharmaceuticals Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 459,532 shares of SNDX stock, worth $6.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

459,532

Previous 556,414 17.41%

Holding current value

$6.43 Million

Previous $11.4 Million 22.57%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.93 - $24.81 $1.74 Million - $2.4 Million	-96,882 Reduced 17.41%	459,532 $8.85 Million
Q2 2024 Aug 09, 2024	BUY	$18.82 - $23.79 $3.08 Million - $3.9 Million	163,728 Added 41.69%	556,414 $11.4 Million
Q1 2024 May 13, 2024	SELL	$19.71 - $24.57 $4.56 Million - $5.68 Million	-231,324 Reduced 37.07%	392,686 $9.35 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $5.13 Million - $9.76 Million	450,571 Added 259.79%	624,010 $13.5 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $181,383 - $271,950	12,492 Added 7.76%	173,439 $2.52 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $187,888 - $216,630	9,710 Added 6.42%	160,947 $3.37 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $131,707 - $184,747	6,375 Added 4.4%	151,237 $3.19 Million
Q4 2022 Feb 14, 2023	SELL	$20.64 - $26.24 $433,749 - $551,433	-21,015 Reduced 12.67%	144,862 $3.69 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $647 - $867	35 Added 0.02%	165,877 $3.99 Million
Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $30,717 - $43,868	2,252 Added 1.38%	165,842 $3.19 Million
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $4,021 - $6,002	-271 Reduced 0.17%	163,590 $2.77 Million
Q4 2021 Feb 14, 2022	SELL	$15.23 - $22.47 $164,621 - $242,878	-10,809 Reduced 6.19%	163,861 $2.93 Million
Q3 2021 Nov 12, 2021	SELL	$13.87 - $19.8 $585,924 - $836,431	-42,244 Reduced 19.47%	174,670 $3.46 Million
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $1.06 Million - $1.98 Million	78,723 Added 56.97%	216,914 $3.73 Million
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $349,874 - $446,234	-18,147 Reduced 11.61%	138,191 $3.09 Million
Q4 2020 Feb 16, 2021	SELL	$15.1 - $26.44 $457,575 - $801,211	-30,303 Reduced 16.24%	156,338 $3.48 Million
Q3 2020 Nov 16, 2020	BUY	$13.39 - $17.48 $928,435 - $1.21 Million	69,338 Added 59.11%	186,641 $2.76 Million
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $377,858 - $886,740	42,266 Added 56.33%	117,303 $1.74 Million
Q1 2020 May 14, 2020	SELL	$6.65 - $12.03 $93,891 - $169,851	-14,119 Reduced 15.84%	75,037 $823,000
Q4 2019 Feb 14, 2020	SELL	$5.43 - $9.22 $324,887 - $551,651	-59,832 Reduced 40.16%	89,156 $783,000
Q3 2019 Nov 14, 2019	BUY	$7.47 - $10.76 $296,977 - $427,774	39,756 Added 36.4%	148,988 $1.11 Million
Q2 2019 Aug 15, 2019	BUY	$4.9 - $9.31 $535,236 - $1.02 Million	109,232 New	109,232 $1.02 Million

Others Institutions Holding SNDX

# of Institutions

230

Shares Held

90M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $792M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Syndax Pharmaceuticals Inc Transaction History